JP2023519518A5 - - Google Patents
Info
- Publication number
- JP2023519518A5 JP2023519518A5 JP2022554199A JP2022554199A JP2023519518A5 JP 2023519518 A5 JP2023519518 A5 JP 2023519518A5 JP 2022554199 A JP2022554199 A JP 2022554199A JP 2022554199 A JP2022554199 A JP 2022554199A JP 2023519518 A5 JP2023519518 A5 JP 2023519518A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900883A AU2020900883A0 (en) | 2020-03-23 | Antisense Oligomers for Treatment of Disease | |
| AU2020900883 | 2020-03-23 | ||
| PCT/AU2021/050261 WO2021189104A1 (en) | 2020-03-23 | 2021-03-22 | Antisense oligomers for treatment of disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519518A JP2023519518A (ja) | 2023-05-11 |
| JPWO2021189104A5 JPWO2021189104A5 (https=) | 2024-03-12 |
| JP2023519518A5 true JP2023519518A5 (https=) | 2024-03-12 |
Family
ID=77889846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022554199A Pending JP2023519518A (ja) | 2020-03-23 | 2021-03-22 | 疾患の処置のためのアンチセンスオリゴマー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230407309A1 (https=) |
| EP (1) | EP4127174A4 (https=) |
| JP (1) | JP2023519518A (https=) |
| CN (1) | CN115397988A (https=) |
| AU (1) | AU2021244774A1 (https=) |
| WO (1) | WO2021189104A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7722666B2 (ja) * | 2020-07-28 | 2025-08-13 | 神戸天然物化学株式会社 | アンギオテンシン変換酵素２遺伝子のエクソンのスキッピングを誘導するアンチセンス核酸 |
| US20240067973A1 (en) * | 2020-12-31 | 2024-02-29 | The First Affiliated Hospital Of Sun Yat-Sen University | Oligonucleotide for reducing the expression of angiotensin-converting enzyme 2 (ACE2) and its use for treating viral infection |
| CA3256035A1 (en) * | 2022-04-14 | 2023-10-19 | Invisishield Technologies Ltd. | COMPOSITIONS FOR PREVENTING OR TREATMENT OF CORONAVIRUS INFECTIONS |
| US20250333744A1 (en) * | 2022-04-14 | 2025-10-30 | Shift Pharmaceuticals Holding Inc. | Polynucleotide Treatments for Charcot-Marie-Tooth Disease |
| WO2023201306A1 (en) | 2022-04-14 | 2023-10-19 | Invisishield Technologies Ltd. | Compositions for preventing or treating influenza infections |
| WO2024233583A2 (en) * | 2023-05-08 | 2024-11-14 | Carisma Therapeutics Inc. | Compositions and methods relating to intronic shrna chimeric antigen receptor constructs |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610497B1 (en) * | 1997-12-11 | 2003-08-26 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| US6989363B1 (en) * | 1997-12-11 | 2006-01-24 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| US20050203038A1 (en) * | 2004-03-10 | 2005-09-15 | Isis Pharmaceuticals Inc. | Modulation of ACE2 expression |
| US20070185044A1 (en) * | 2005-03-08 | 2007-08-09 | Dobie Kenneth W | Modulation of ace2 expression |
| EP1857548A1 (en) * | 2006-05-19 | 2007-11-21 | Academisch Ziekenhuis Leiden | Means and method for inducing exon-skipping |
| CN111979273B (zh) * | 2020-08-24 | 2022-05-27 | 苏州启辰生物科技有限公司 | 一种制备人源化ace2小鼠模型的方法 |
-
2021
- 2021-03-22 US US17/909,947 patent/US20230407309A1/en active Pending
- 2021-03-22 WO PCT/AU2021/050261 patent/WO2021189104A1/en not_active Ceased
- 2021-03-22 AU AU2021244774A patent/AU2021244774A1/en active Pending
- 2021-03-22 EP EP21776876.1A patent/EP4127174A4/en not_active Withdrawn
- 2021-03-22 CN CN202180023548.6A patent/CN115397988A/zh active Pending
- 2021-03-22 JP JP2022554199A patent/JP2023519518A/ja active Pending